Assessing patients with fibromyalgia from a rheumatologist's perspective: A three-step methodology for differential diagnosis

International Journal of Clinical Rheumatology

Volumn 4, Issue 4, 2009, Pages 409-419

  Holman, Andrew J ^a  

^a Pacific Rheumatology Research   (United States)

Author keywords

Central sensitization; Cervical myelopathy; Dysautonomia; Fibromyalgia; Pain

Indexed keywords

DULOXETINE; MILNACIPRAN; PREGABALIN;

ALLODYNIA; ANXIETY DISORDER; AROUSAL; ARTICLE; AUTONOMIC DYSFUNCTION; BIPOLAR DISORDER; BLADDER IRRITATION; CLINICAL FEATURE; COMORBIDITY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DIZZINESS; DRUG APPROVAL; DYSAUTONOMIA; DYSPEPSIA; ENDOCRINE DISEASE; FATIGUE; FIBROMYALGIA; FLUSHING; HEART PALPITATION; HUMAN; HYPOGLYCEMIA; INTERSTITIAL CYSTITIS; IRRITABLE COLON; MOOD DISORDER; NIGHTMARE; ORTHOSTATIC HYPOTENSION; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RESTLESS LEGS SYNDROME; RHEUMATOLOGY; SENSITIVITY AND SPECIFICITY; SLEEP DISORDER; SYMPTOM; TACHYCARDIA;

EID: 71249154750     PISSN: 17584272     EISSN: None     Source Type: Journal    
DOI: 10.2217/ijr.09.31     Document Type: Article

References (67)

1. Wolfe F, Smythe HA, Yunus MB et al.: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum. 33(2), 160-172 (1990).
2. Thomas SL, Edwards CJ, Smeeth L, Cooper C, Hall AJ: How accurate are diagnoses for rheumatoid arthritis and juvenile idiopathic arthritis in general practice research database? Arthritis Rheum. 59(9), 1314-1321 (2008).
3. Bernatsky S, Joseph L, Pineau CA, Tamblyn R, Feldman DE, Clarke AE: A population-based assessment of systemic lupus erythematosus incidence and prevalence: results and implications of using administrative data for epidemiological studies. Rheumatology (Oxford) 46(12), 1814-1818 (2007).
4. Fernández-Sueiro JL, Willisch A, Pértega-Díaz S et al.: Evaluation of ankylosing spondylitis mobility measurements in the assessment of spinal involvement in psoriatic arthritis. Arthritis Rheum. 61(3), 386-392 (2009).
5. Branco JC, Bannwarth B, Failde I et al.: Prevalence of fibromyalgia: a survey in five European countries. Semin. Arthritis Rheum. DOI 10.1016/j.semarthrit.2008.12.003 (2009) (Epub ahead of print).
6. Lawrence RC, Felson DT, Helmick CG et al.: Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 58(1), 26-35 (2008).
7. Russell IJ: Is fibromyalgia a distinct clinical entity? The clinical investigator's evidence. Baillieres Best Pract. Res. Clin. Rheumatol. 13(3), 445-454 (1999).
8. Arnold LM, Crofford LJ, Mease PJ et al.: Patient perspectives on the impact of fibromyalgia. Patient Educ. Couns. 73(1), 114-120 (2008).
9. Holman AJ: Pragmatic consideration of recent randomized, placebo-controlled clinical trials for treatment of fibromyalgia. Curr. Pain Headache Rep. 12, 393-398 (2008).
10. Moldofsky H, Scarisbrick P, England R et al.: Musculoskeletal symptoms and non-REM sleep disturbance in patients with 'fibrositis syndrome' and healthy subjects. Psychosom. Med. 37, 341-351 (1975).
11. Moldofsky H, Scarisbrick P: Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom. Med. 38(1), 35-44 (1976).
12. Lentz MJ, Landis CA, Rothermel J et al.: Effects of selective slow wave sleep disruption on musculoskeletal pain and fatigue in middle aged women. J. Rheumatol. 26(7), 1586-1592 (1999).
13. Older SA, Battafarano DF, Danning CL et al.: The effects of delta wave sleep interruption on pain thresholds and fibromyalgia-like symptoms in healthy subjects; correlations with insulin-like growth factor I. J. Rheumatol. 25(6), 1180-1186 (1998).
14. Rupp TL, Wesensten NJ, Bliese PD et al.: Banking sleep: realization of benefits during subsequent sleep restriction and recovery. Sleep 32(3), 311-321 (2009).
15. González-Ortiz M, Martínez-Abundis E: Impact of sleep deprivation on insulin secretion, insulin sensitivity, and other hormonal regulations. Metab. Syndr. Relat. Disord. 3(1), 3-7 (2005).
16. Bigatti SM, Hernandez AM, Cronan TA, Rand KL: Sleep disturbances in fibromyalgia syndrome: relationship to pain and depression. Arthritis Rheum. 59(7), 961-967 (2008).
17. Issa EB, Wang X: Sensory responses during sleep in primate primary and secondary auditory cortex. J. Neurosci. 28(53), 14467-14480 (2008).
18. 2+ channels controls pain sensory gating in the thalamus. J. Neurosci. 28(49), 13331-13340 (2008).
19. Wagner G, Koschke M, Leuf T et al.: Reduced heat pain thresholds after sad-mood induction are associates with changes in thalamic activity. Neuropsychologia 47(4), 980-987 (2009).
20. Gracely RH, Petzke F, Wolf JM et al.: Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum. 46(5), 1333-1343 (2002).
21. Martinez-Lavin MM: Biology and therapy of fibromyalgia. Stress, the stress response system, and fibromyalgia. Arthritis Res. Ther. 9(4), 216 (2007).
22. Vaeroy H, Qiao ZG, Morkrid L, Forre O: Altered sympathetic nervous system response in patients with fibromyalgia (fibrositis syndrome). J. Rheum. 16(11), 1460-1465 (1998).
23. Raj SR, Brouillard D, Simpson CS et al.: Dysautonomia among patients with fibromyalgia; a noninvasive assessment. J. Rheum. 27, 2660-2665 (2000).
24. Martinez-Lavin M, Hermosillo AG: Autonomic nervous system dysfunction may explain the multisystem features of fibromyalgia. Semin. Arthritis Rheum. 29(4), 197-199 (2000).
25. Petzke F, Clauw DJ: Sympathetic nervous system function in fibromyalgia. Curr. Rheumatol. Rep. 2(2), 116-123 (2000).
26. Martinez-Lavin M, Hermosillo AG, Rosas M et al.: Circadian studies of autonomic nervous balance in patients with fibromyalgia: a heart variability ana lysis. Arthritis Rheum. 41(11), 1966-1971 (1998).
27. Giske L, Vøllestad NK, Mengshoel AM et al.: Attenuated adrenergic responses to exercise in women with fibromyalgia - a controlled study. Eur. J. Pain 12(3), 351-360 (2008).
28. Wolfe F, Michaud K: Outcome and predictor relationships in fibromyalgia and rheumatoid arthritis: evidence concerning the continuum versus discrete disorder hypothesis. J. Rheum. 36, 831-836 (2009).
29. Hadler NM: Occupational Musculoskeletal Disorders (3rd Edition, Illustrated). Lippincott Williams & Wilkins, PA, USA (2004).
30. Jenkins CD, Stanton BA, Niemcryk SJ et al.: A scale for the estimation of sleep problems in clinical research. J. Clin. Epidemiol. 41(4), 313-321 (1988).
31. Burckhardt CS, Clark SR, Bennett RM: The fibromyalgia impact questionnaire: development and validation. J. Rheum. 18(5), 728-733 (1991).
32. Kundermann B, Hemmeter-Spernal J, Huber MT, Krieg JC, Lautenbacher S: Effects of total sleep deprivation in major depression: overnight improvements of mood is accompanied by increased pain sensitivity and augmented pain complaints. Psychosom. Med. 70(1), 92-101 (2008).
33. Parish JM: Sleep-related problems in common medical conditions. Chest 135(2), 563-572 (2009).
34. Solano C, Martinez A, Becerril L et al.: Autonomic dysfunction assessed by the Composite Autonomic Symptom Scale (COMPASS). J. Clin. Rheumatol. 15(4), 172-176 (2009).
35. Holman AJ: Positional cervical spinal cord compression and fibromyalgia: a novel comorbidity with important diagnostic and treatment implications. J. Pain 9(7), 613-622 (2008).
36. Krassioukov AV, Fehlings MG: Effect of graded spinal cord compression on cardiovascular neurons in the rostro-ventro-lateral medulla. Neuroscience 88(3), 959-973 (1999).
37. Karlsson AK: Autonomic dysfunction in spinal cord injury: clinical presentation of symptoms and signs. Prog. Brain Res. 152, 1-8 (2006).
38. Banic B, Petersen-Felix S, Andersen OK et al.: Evidence for spinal cord hypersensitivity in chronic pain after whiplash injury and in fibromyalgia. Pain 107(1-2), 7-15 (2004).
39. Heffez DS, Ross RE, Shade-Zeldow Y et al.: Clinical evidence for cervical myelopathy due to Chiari malformation and spinal stenosis in a non-randomized group of patients with the diagnosis of fibromyalgia. Eur. Spine J. 13(6), 516-523 (2004).
40. Heffez DS, Ross RE, Shade-Zeldow Y et al.: Treatment of cervical myelopathy in patients with the fibromyalgia syndrome: outcomes and implications. Eur. Spine J. 16(9), 1423-1433 (2007).
41. Sheer FAJL, Zietzer JM, Brown R et al.: Reduced sleep efficiency in cervical spinal cord injury: association with abolished night time melatonin secretion. Spinal Cord 44, 78-81 (2006).
42. Julien N, Goffaux P, Arsenault P et al.: Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 114(1-2), 295-302 (2005).
43. Millian MJ: Descending control of pain. Prog. Neurobiol. 66, 355-474 (2002).
44. Germanowicz D, Lumertz MS, Martinez D et al.: Sleep disordered breathing concomitant with fibromyalgia syndrome. J. Bras. Pneumol. 32(4), 333-338 (2006).
45. Disdier P, Genton P, Milandre C et al.: Fibrositis syndrome and narcolepsy. J. Rheumatol. 20(5), 888-889 (1993).
46. Russell IJ, Perkins AT, Michalek JE et al.: Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial. Arthritis Rheum. 60(1), 299-309 (2009).
47. Stepanski EJ, Wyatt JK: Use of sleep hygiene in the treatment of insomnia. Sleep Med. Rev. 7(3), 215-225 (2003).
48. Remvig L, Jensen DV, Ward RC: Epidemiology of general joint hypermobility and basis for the proposed criteria for benign joint hypermobility syndrome: review of the literature. J. Rheumatol. 34(4), 804-809 (2007).
49. Klemp P, Williams SM, Stansfield SA: Articular mobility in Maori and European New Zealanders. Rheumatology (Oxford) 41, 554-557 (2002).
50. Birrell FN, Adebajo AO, Hazleman BL, Silman AJ: High prevalence of joint laxity in West Africans. Br. J. Rheumatol. 22, 56-59 (1994).
51. Gazit Y, Nahir AM, Grahame R et al.: Dysautonomia in the joint hypermobility syndrome. Am. J. Med. 115(1), 33-40 (2003).
52. Acasuso-Díaz M, Collantes-Estévez E: Joint hypermobility in patients with fibromyalgia syndrome. Arthritis Care Res. 11(1), 39-42 (1998).
53. Holman AJ: Is hypermobility a factor in fibromyalgia? J. Rheumatol. 29(2), 396-398 (2002).
54. Bulbena A, Agulló A, Pailhez G et al.: Is joint hypermobility related to anxiety in a nonclinical population also? Psychosomatics 45(5), 432-437 (2004).
55. Holman AJ, Myers RR: A randomized, double-blind, placebo controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum. 52(8), 2495-2505 (2005).
56. Van Houdenhove B, Neerinckx E, Lysens R et al.: Victimization in chronic fatigue syndrome and fibromyalgia in tertiary care: a controlled study on prevalence and characteristics. Psychosomatics 42(1), 21-28 (2001).
57. Block SR: Vitamin D deficiency is not associated with nonspecific musculoskeletal pain syndromes including fibromyalgia. Mayo Clin. Proc. 79(12), 1585-1586 (2004).
58. Gerwin RD: A review of myofascial pain and fibromyalgia - factors that promote their persistence. Acupunct. Med. 23(3), 121-134 (2005).
59. Armstrong DJ, Meenagh GK, Bickle I et al.: Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin. Rheumatol. 26(4), 551-554 (2007).
60. Warner AE, Arnspiger SA: Diffuse musculoskeletal pain is not associated with low vitamin D levels or improved by treatment with vitamin D. J. Clin. Rheumatol. 14(1), 12-16 (2008).
61. Mouyis M, Ostor AJ, Crisp AJ et al.: Hypovitaminosis D among rheumatology outpatients in clinical practice. Rheumatology (Oxford) 47(9), 1348-1351 (2008).
62. Dessein PH, Shipton EA, Joffe BI et al.: Hyposecretion of adrenal androgens and the relation of serum adrenal steroids, serotonin and insulin-like growth factor-1 to clinical features in women with fibromyalgia. Pain 83(2), 313-319 (1999).
63. Nilsson E, de la Torre B, Hedman M et al.: Blood dehydroepiandrosterone sulphate (DHEAS) levels in polymyalgia rheumatica/giant cell arteritis and primary fibromyalgia. Clin. Exp. Rheumatol. 12(4), 415-417 (1994).
64. Nolan J, Batin PD, Andrews R et al.: Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment risk trial (UK-heart). Circulation 98(15), 1510-1516 (1998).
65. Liao D, Cai J, Rosamond W et al.: Cardiac autonomic function and incident coronary heart disease: a population-based case-cohort study. The ARIC Study Atherosclerosis Risk in communities Study. Am. J. Epidemiol. 145(8), 696-706 (1997).
66. Dekker JM, Schouten EG, Klootwijk P et al.: Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-ages and elderly men. Am. J. Epidemiol. 145(10), 899-908 (1997).
67. Holman AJ, Ng E: Heart rate variability predicts anti-tumor necrosis factor therapy response for inflammatory arthritis. Auton. Neurosci. 143(1-2), 58-67 (2008).